Skip to main content

MoneyWorks4Me

Piramal Pharma informs about analyst meet

23 May 2023 Evaluate
Pursuant to Regulation 30(6) of the Listing Regulations, Piramal Pharma has informed that it enclosed herewith the details of the Conference Call with investors/ analysts to be held on 25th May, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..